The First International Pharmaceutical Conference “Import substitution 2015” took place in the House of the Moscow Region Government in Krasnogorsk on June 10. The event was held with the cooperation and support of the Government of the Moscow Region and the Ministry of Industry and Trade of the Russian Federation. Andrey Vorobyov, Governor of the Moscow region, was the chairman of the conference. The conference was dedicated to the region’s pharmclusters development prospects and gathered managers of the leading Russian pharmaceutical companies, representatives of distributors and pharmacy chains, physicians of Moscow region hospitals as well as representatives of the federal and regional ministries and departments. At the conference state support measures necessary for development of the industry in the current economical environment were discussed. The participants also analysed an import substitution strategy and ways to improve the availability and affordability of medical products.
As part of interactive discussion “New Russian pharmaceutical
industry. Response to modern healthcare challenges” practical
suggestions of manufacturers, aimed at raising awareness of medical
community, were submitted.
Dmitry Burovik, Director of GEROPHARM-Bio (a part of GEROPHARM, Group of Companies) made a report “Development of pharmaceutical substances manufacturing in the region. Challenges, achievements and prospects”. In this report he drew attention to the need of development of production with maximum local content, i.e. industrial production of substances. Only full circle production including the production of pharmaceutical substances can ensure real import substitution and improve drug safety of the country.
Natalia Novichkova, Quality Director of GEROPHARM, made a report on a quality assurance system implemented at the comany’s factory. She told about this system during the round table “Assurance of quality, efficiency and safety of drugs is the common goal of regulatory authorities and manufacturers” which was held at the same time. Natalia Novichkova presented practical cases and told about the development of validation system at the factory.
The representatives of the Ministry of Industry and Trade, the Ministry for Economic Development, the Ministry of Health and the Federal Service on Surveillance in Healthcare and Social Development of Russian Federation told about the opportunities for the development of the pharmaceutical industry in Russia. The representatives of the Ministry of Investments and Innovations of the Moscow region shared the experience of pharmclusters development on the example of regional initiatives.
As the result of the First International Pharmaceutical Conference “Import substitution 2015”, the Federal Service on Surveillance in Healthcare and Social Development of Russian Federation and the Government of the Moscow region concluded an agreement on the formation of a unified system of non-clinical and clinical trial based on the exiting federal laboratory infrastructure and the clinical site of the Moscow region in the interests of pharmaceuticals manufacturers for the Central Federal District.
An exhibition was held as a part of the conference. The leading Russian companies provided participants an opportunity to learn more about their product portfolio and the most recent developments. GEROPHARM, Group of Companies, allowed the participants not only to see company’s drug products and unique 3D model of the GEOPHARM-Bio factory, but also to take a virtual tour on the company’s modern production line and check out high level and quality of manufactured products. An interactive table located at the company’s exhibition stand made it possible to take the virtual tour on the production line and see stages of production of modern and hi-tech GEROPHARM products.
Today the Moscow region is one of the biggest constituent entities of the Russian Federation in terms of concentration of pharmaceutical factories. 26 pharmaceutical factories are located in the region. They produce innovative products, as well as branded and non-branded generic products, veterinary drugs. Overall revenue of the companies exceeds 40 million roubles per year, and four of these companies (Akrikhin, Valenta Pharm, KRKA-Rus and Sotex) belong to Top 15 pharmaceutical companies of Russia in terms of revenue (according to SPARK analytic system and Deloitte analysis for 2014). There are three pharmclusters in the Moscow region: Pushchinsky (in Serpukhovsky District), Severny (both Krasnogorsk and Khimkinsky District) and Shchelkovsko-Noginsky.
“In the previous year the Government of the Moscow region managed to implement a number of initiatives contributing the development of pharmaceutical industry and promoting health care in the region”, said Aleksandr Ganov, Minister of Investments and Innovations of the Moscow region. He added: “In order to move forward, it is important to receive feedback from representatives of the pharmaceutical industry and physicians. Currently, we actively work together with the state federal authorities on the pilot projects”.